Maintained Complete Response and Long-Term Survival in Epidermal Growth Factor Receptor Mutated Metastatic Non-Small Cell Lung Cancer with Erlotinib

The prognosis of advanced non-small cell lung cancer (NSCLC) has significantly improved for certain patients with the development of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). However, metastatic NSCLC patients with long-term survival are still rare. Our 66-year-old mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkassis, Samer, Alshare, Bayan, Ahmed, Shabbir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853695/
https://www.ncbi.nlm.nih.gov/pubmed/33552769
http://dx.doi.org/10.7759/cureus.12451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853695/
https://www.ncbi.nlm.nih.gov/pubmed/33552769
http://dx.doi.org/10.7759/cureus.12451

Ejemplares similares